Chiang, C. L., Chan, S. L., Chan, S., Lee, A. S., Chiu, K., Wong, N. S. M., Chan, L., Lee, V. W. Y., Yeung, V. T. Y., Ho, R., Lau, V. W. H., Man, N. K., Kong, F. (., Chan, A. (2026). Sequential transarterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy using single tremelimumab regular interval durvalumab in locally advanced, unresectable HCC (START-FIT using STRIDE): A single-arm, phase II, multi-centre study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.540